PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD conducts clinical trials around the world that involve the testing of new drugs or delivery methods to determine safety and effectiveness.
PPD News and Events Media kit
As the leading CRO in rare disease research, we are excited to share our insights with you at WODC 2019. We deploy flexible, patient-centric study designs to drive success in patient recruitment and retention. Visit us at booth #401, or set up a customized meeting with one of our experts. We look forward to meeting you.
NATIONAL HARBOR, MARYLAND
Wednesday through Friday, 10-12 April 2019
Please fill out the following form to request a meeting that will be customized to meet your needs.
Patient-Focused Rare Disease Clinical Trial Protocols—Patient-Centered Outcomes and Beyond
Thursday, 11 April, 12:40 p.m. (EDT)
Margaret Vernon, VP & General Manager, Patient-Centered Research, Evidera
Kevin Marsh, PhD, Executive Director, Commercial Strategy & New Product Development, Patient-Centered Research, Evidera
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.